182 related articles for article (PubMed ID: 10821876)
1. Effects of age on serum dehydroepiandrosterone sulfate, IGF-I, and IL-6 levels in women.
Haden ST; Glowacki J; Hurwitz S; Rosen C; LeBoff MS
Calcif Tissue Int; 2000 Jun; 66(6):414-8. PubMed ID: 10821876
[TBL] [Abstract][Full Text] [Related]
2. Decreased serum IGF-I and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism.
Földes J; Lakatos P; Zsadányi J; Horváth C
Eur J Endocrinol; 1997 Mar; 136(3):277-81. PubMed ID: 9100552
[TBL] [Abstract][Full Text] [Related]
3. The relationship between serum dehydroepiandrosterone sulfate concentration and bone mineral density, lipids, and hormone replacement therapy in premenopausal and postmenopausal women.
Osmanagaoglu MA; Okumuş B; Osmanagaoglu T; Bozkaya H
J Womens Health (Larchmt); 2004 Nov; 13(9):993-9. PubMed ID: 15665656
[TBL] [Abstract][Full Text] [Related]
4. Dehydroepiandrosterone sulphate in the diagnosis of osteoporosis.
Miklós S
Acta Biomed Ateneo Parmense; 1995; 66(3-4):139-46. PubMed ID: 8578930
[TBL] [Abstract][Full Text] [Related]
5. Endogenous sex steroid, GH and IGF-I levels in normal elderly men: relationships with bone mineral density and markers of bone turnover.
Gürlek A; Gedik O
J Endocrinol Invest; 2001 Jun; 24(6):408-14. PubMed ID: 11434664
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures.
Sugimoto T; Nishiyama K; Kuribayashi F; Chihara K
J Bone Miner Res; 1997 Aug; 12(8):1272-9. PubMed ID: 9258758
[TBL] [Abstract][Full Text] [Related]
7. Association of dehydroepiandrosterone sulfate, body composition, and physical fitness in independent community-dwelling older men and women.
Abbasi A; Duthie EH; Sheldahl L; Wilson C; Sasse E; Rudman I; Mattson DE
J Am Geriatr Soc; 1998 Mar; 46(3):263-73. PubMed ID: 9514370
[TBL] [Abstract][Full Text] [Related]
8. Relationship between insulin-like growth factor I, dehydroepiandrosterone sulfate and proresorptive cytokines and bone density in cystic fibrosis.
Gordon CM; Binello E; LeBoff MS; Wohl ME; Rosen CJ; Colin AA
Osteoporos Int; 2006; 17(5):783-90. PubMed ID: 16541207
[TBL] [Abstract][Full Text] [Related]
9. Independent association between insulin-like growth factor-I and dehydroepiandrosterone sulphate in women in middle adulthood.
Kasayama S; Morita S; Otsuki M; Asanuma N; Saito H; Mukai M; Koga M
Clin Endocrinol (Oxf); 2007 Jun; 66(6):797-802. PubMed ID: 17381481
[TBL] [Abstract][Full Text] [Related]
10. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
Vermeulen A; Kaufman JM; Giagulli VA
J Clin Endocrinol Metab; 1996 May; 81(5):1821-6. PubMed ID: 8626841
[TBL] [Abstract][Full Text] [Related]
11. Association between DHEAS and bone loss in postmenopausal women: a 15-year longitudinal population-based study.
Ghebre MA; Hart DJ; Hakim AJ; Kato BS; Thompson V; Arden NK; Spector TD; Zhai G
Calcif Tissue Int; 2011 Oct; 89(4):295-302. PubMed ID: 21789637
[TBL] [Abstract][Full Text] [Related]
12. CYP3A7*1C polymorphism, serum dehydroepiandrosterone sulfate level, and bone mineral density in postmenopausal women.
Bácsi K; Kósa JP; Borgulya G; Balla B; Lazáry A; Nagy Z; Horváth C; Speer G; Lakatos P
Calcif Tissue Int; 2007 Mar; 80(3):154-9. PubMed ID: 17334880
[TBL] [Abstract][Full Text] [Related]
13. Biochemical markers of bone remodeling correlate negatively with circulating TSH in postmenopausal women.
Zofkova I; Hill M
Endocr Regul; 2008 Sep; 42(4):121-7. PubMed ID: 18999899
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance and advancing age: what role for dehydroepiandrosterone sulfate?
Paolisso G; Ammendola S; Rotondi M; Gambardella A; Rizzo MR; Mazziotti G; Tagliamonte MR; Carella C; Varricchio M
Metabolism; 1997 Nov; 46(11):1281-6. PubMed ID: 9361686
[TBL] [Abstract][Full Text] [Related]
15. The relationship among circulating insulin-like growth factor components, biochemical markers of bone turnover and bone mineral density in postmenopausal women under the age of 60.
Kim JG; Shin CS; Choi YM; Moon SY; Kim SY; Lee JY
Clin Endocrinol (Oxf); 1999 Sep; 51(3):301-7. PubMed ID: 10469009
[TBL] [Abstract][Full Text] [Related]
16. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence.
Straub RH; Konecna L; Hrach S; Rothe G; Kreutz M; Schölmerich J; Falk W; Lang B
J Clin Endocrinol Metab; 1998 Jun; 83(6):2012-7. PubMed ID: 9626133
[TBL] [Abstract][Full Text] [Related]
17. Dehydroepiandrosterone and Bone.
Zhou S; Glowacki J
Vitam Horm; 2018; 108():251-271. PubMed ID: 30029729
[TBL] [Abstract][Full Text] [Related]
18. Increases in bone mineral density in response to oral dehydroepiandrosterone replacement in older adults appear to be mediated by serum estrogens.
Jankowski CM; Gozansky WS; Kittelson JM; Van Pelt RE; Schwartz RS; Kohrt WM
J Clin Endocrinol Metab; 2008 Dec; 93(12):4767-73. PubMed ID: 18812486
[TBL] [Abstract][Full Text] [Related]
19. Relationships between insulin-like growth factor-I (IGF-I) and OPG, RANKL, bone mineral density in healthy Chinese women.
Zhao HY; Liu JM; Ning G; Zhao YJ; Chen Y; Sun LH; Zhang LZ; Xu MY; Chen JL
Osteoporos Int; 2008 Feb; 19(2):221-6. PubMed ID: 17703270
[TBL] [Abstract][Full Text] [Related]
20. Hyposecretion of adrenal androgens and the relation of serum adrenal steroids, serotonin and insulin-like growth factor-1 to clinical features in women with fibromyalgia.
Dessein PH; Shipton EA; Joffe BI; Hadebe DP; Stanwix AE; Van der Merwe BA
Pain; 1999 Nov; 83(2):313-9. PubMed ID: 10534604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
